1995
DOI: 10.1016/s0002-9343(99)80105-3
|View full text |Cite
|
Sign up to set email alerts
|

Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: Evidence for frequent serologic relapse after therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
56
1
6

Year Published

2003
2003
2024
2024

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(63 citation statements)
references
References 21 publications
0
56
1
6
Order By: Relevance
“…Compared with HIV-uninfected patients, HIV-infected patients with symptomatic neurosyphilis may be more likely to fail neurosyphilis therapy based on clinical and serological criteria, as well as on failure to normalise CSF abnormalities. 32,[59][60][61][62][63][64] In one prospective study, HIV-infected patients were 2.5-fold less likely to normalise CSF-VDRL after appropriate therapy compared with HIV-uninfected patients. 63 In addition, HIV-infected patients with peripheral blood CD4+ T-cells 200 cells uL -1 were 3.3-fold less likely to normalise CSF-VDRL.…”
Section: Treatment Of Neurosyphilismentioning
confidence: 99%
“…Compared with HIV-uninfected patients, HIV-infected patients with symptomatic neurosyphilis may be more likely to fail neurosyphilis therapy based on clinical and serological criteria, as well as on failure to normalise CSF abnormalities. 32,[59][60][61][62][63][64] In one prospective study, HIV-infected patients were 2.5-fold less likely to normalise CSF-VDRL after appropriate therapy compared with HIV-uninfected patients. 63 In addition, HIV-infected patients with peripheral blood CD4+ T-cells 200 cells uL -1 were 3.3-fold less likely to normalise CSF-VDRL.…”
Section: Treatment Of Neurosyphilismentioning
confidence: 99%
“…Some studies found a slower serologic response in HIV infected patients, but other did not. Also, a higher risk of serological failure was associated with HIV infection (Ghanem et al, 2007;Gonzalez-Lopez et al, 2009;Kofoed et al, 2006;Malone et al, 1995;Telzak et al, 1991;Walter et al, 2006;Yinnon et al, 1996).…”
Section: Syphilis In Hiv-infected Patientsmentioning
confidence: 99%
“…Treatment failure was not related with CD4 count or to a specific antimicrobial regimen. However, the results suggest that patients with clinical evidence of secondary syphilis or with reactive cerebrospinal fluid VDRL test titers were at highest risk of subsequent relapse or treatment failure when monitored for an average of 2 years (Malone et al, 1995). Rolfs et al performed a study of randomized trial of enhanced therapy for early syphilis in 541 patients including 101 patients who had HIV infection.…”
Section: Pre-haartmentioning
confidence: 99%
“…14 Entretanto, apesar do tratamento com penicilina diminuir os títulos séricos do VDRL (Venereal Disease Research Laboratory), mostrou-se inadequado, em quase todos os doentes HIV-positivos, na prevenção da recidiva clínica e sorológica. 15,16 Para controle de cura é necessária a dosagem trimestral dos títulos de VDRL sérico até completar um ano. 4,5,13 É desejável que esses títulos permaneçam positivos em até 1:4.…”
Section: Introductionunclassified